Your browser is no longer supported. Please, upgrade your browser.
Qualigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.46 Insider Own0.80% Shs Outstand26.82M Perf Week-15.45%
Market Cap54.76M Forward P/E- EPS next Y-0.56 Insider Trans13.60% Shs Float23.79M Perf Month-30.08%
Income-21.20M PEG- EPS next Q-0.16 Inst Own5.00% Short Float7.46% Perf Quarter-51.94%
Sales2.80M P/S19.56 EPS this Y95.80% Inst Trans17.57% Short Ratio1.48 Perf Half Y-53.85%
Book/sh0.68 P/B2.74 EPS next Y53.30% ROA-130.20% Target Price- Perf Year-83.09%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.71 - 19.75 Perf YTD-38.21%
Dividend- P/FCF- EPS past 5Y73.00% ROI-62.20% 52W High-90.58% Beta-0.83
Dividend %- Quick Ratio2.60 Sales past 5Y- Gross Margin7.30% 52W Low8.77% ATR0.18
Employees34 Current Ratio2.70 Sales Q/Q-30.30% Oper. Margin- RSI (14)33.87 Volatility6.49% 9.46%
OptionableYes Debt/Eq0.01 EPS Q/Q127.90% Profit Margin- Rel Volume0.35 Prev Close1.91
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.20M Price1.86
Recom2.00 SMA20-10.34% SMA50-29.73% SMA200-51.46% Volume423,886 Change-2.62%
Apr-26-21 07:00AM  
Apr-19-21 01:16PM  
Apr-06-21 09:30AM  
Mar-18-21 08:30AM  
Mar-09-21 08:30AM  
Mar-08-21 08:30AM  
Mar-01-21 08:30AM  
Jan-26-21 09:00AM  
Dec-30-20 11:16AM  
Dec-22-20 09:00AM  
Dec-18-20 03:07PM  
Dec-16-20 10:25AM  
Dec-15-20 09:00AM  
Dec-08-20 09:00AM  
Dec-02-20 09:00AM  
Nov-30-20 09:40AM  
Nov-13-20 09:00AM  
Nov-05-20 09:00AM  
Oct-28-20 09:00AM  
Oct-08-20 09:00AM  
Oct-01-20 09:00AM  
Sep-21-20 11:53AM  
Sep-17-20 09:00AM  
Aug-31-20 09:00AM  
Aug-28-20 08:00AM  
Aug-20-20 08:00AM  
Aug-14-20 05:24PM  
Aug-06-20 03:59PM  
Aug-04-20 04:05PM  
Aug-02-20 05:32PM  
Jul-30-20 08:00AM  
Jul-22-20 08:00AM  
Jul-13-20 08:00AM  
Jul-10-20 04:05PM  
Jul-08-20 05:19PM  
Jul-07-20 08:00AM  
Jul-01-20 08:00AM  
Jun-10-20 08:00AM  
Jun-04-20 08:00AM  
Jun-02-20 08:00AM  
May-26-20 07:00AM  
Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen, Inc. was founded in 1996 and is based in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROIDRICK AMY S.EVP, Chief Strategy OfficerApr 26Buy2.034,5009,1354,500Apr 26 06:16 PM
Poirier Michael S.Chairman, CEO & PresidentApr 20Buy1.8011,00519,80911,005Apr 21 03:18 PM
Lotz Christopher L.Vice President of Finance, CFOApr 16Buy1.862,7005,02212,541Apr 19 06:15 AM
Kruger Kurt HDirectorDec 29Buy2.944,00011,74010,000Dec 30 06:05 AM
Kruger Kurt HDirectorNov 23Buy3.464,60015,9256,000Nov 23 09:11 PM
Kruger Kurt HDirectorNov 20Buy3.551,4004,9691,400Nov 23 09:11 PM